Marimed (MRMD) Share-based Compensation (2011 - 2026)
Marimed (MRMD) reported Share-based Compensation of $325000.0 for Q1 2026, down 40.59% year-over-year from $547000.0 in Q1 2025, and down 14.92% quarter-over-quarter from $382000.0 in Q4 2025.
Marimed (MRMD) Share-based Compensation (2011 - 2026) Analysis & Trends
Marimed (MRMD) has 12 years of Share-based Compensation data on file, last reported at $325000.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $325000.0, down 40.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 21.06% YoY), and the FY2025 annual result was $1.9 million, up 77.14% from the prior year.
- Share-based Compensation declined to $325000.0 in Q1 2026 per MRMD's latest filing, from $382000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $2.6 million in Q2 2022 and troughed at -$58000.0 in Q4 2022.
- A 5-year average of $625882.4 and a median of $297000.0 in 2023 frame the typical range for Share-based Compensation.
- On a YoY basis, Share-based Compensation climbed as much as 477.59% in 2023 and fell as far as 91.58% in 2023.
- A 5-year view of Share-based Compensation shows it stood at -$58000.0 in 2022, then surged by 477.59% to $219000.0 in 2023, then advanced by 26.94% to $278000.0 in 2024, then soared by 37.41% to $382000.0 in 2025, then decreased by 14.92% to $325000.0 in 2026.
- Business Quant data shows MRMD's Share-based Compensation at $325000.0 in Q1 2026, $382000.0 in Q4 2025, and $382000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Marimed | - | - | 15.28 Mn | 325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325,000.00 |
| Mar 31, 2026 | 325,000.00 |
| Dec 31, 2025 | 382,000.00 |
| Dec 31, 2025 | 382,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Dec 31, 2023 | 219,000.00 |